Effect of intravenous thrombolysis combined with mild hypothermia on the levels of IL‑1β, IL‑6, ICAM‑1 and MMP‑2 in patients with acute cerebral infarction and clinical significance

Li,Chaosheng; Hu,Lingling; Zhao,Jilai; Di,Meiqi; Fan,Changyan; Han,Likun; Zhu,Xuying

doi:10.3892/etm.2022.11147

Effect of intravenous thrombolysis combined with mild hypothermia on the levels of IL‑1β, IL‑6, ICAM‑1 and MMP‑2 in patients with acute cerebral infarction and clinical significance

Authors:
- Chaosheng Li
- Lingling Hu
- Jilai Zhao
- Meiqi Di
- Changyan Fan
- Likun Han
- Xuying Zhu
View Affiliations

Affiliations: Department of Neurology, Wuxi Third People's Hospital, Wuxi, Jiangsu 214000, P.R. China, Department of Neurology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China
Published online on: January 17, 2022 https://doi.org/10.3892/etm.2022.11147
Article Number: 223

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to explore the effects and clinical importance of serum interleukin (IL) IL‑1β, IL‑6, C‑reactive protein (CRP), intercellular adhesion molecule (ICAM)‑1 and matrix metalloproteinase (MMP)‑2 in patients with acute cerebral infarction undergoing intravenous thrombolysis during simultaneous hypothermia therapy. A total of 80 patients with acute cerebral infarction who were treated at our hospital were randomly selected. They were divided into groups A and B. The two groups were treated with intravenous thrombolysis, while group B received sub‑hypothermia treatment. Prior to treatment and at 7 days after treatment, 5 ml of venous blood was collected and stored in a freezer at ‑80˚C. IL‑1β, IL‑6, CRP, ICAM‑1 and MMP‑2 levels were detected by ELISA and compared between the groups and time‑points. The results were as follows: i) At 7 days after treatment, the levels of IL‑1β, IL‑6, CRP, ICAM‑1 and MMP‑2 in group B were significantly decreased compared with those in group A (P<0.05), while there was no significant difference of these levels between group A and B before treatment (P>0.05). The incidence of adverse reactions in group A and group B was 35 and 20% respectively, and the mortality rate was 10 and 5%, respectively. There were no significant differences in adverse events and mortality between the two groups (P>0.05). In addition, a positive correlation of the level of IL‑1β, IL‑6, CRP, ICAM‑1 and MMP‑2 with the National Institutes of Health Stroke Scale score was determined in the patients prior to treatment. In conclusion, mild hypothermia treatment in addition to intravenous thrombolysis significantly reduced the levels of IL‑1β, IL‑6, CRP, ICAM‑1 and MMP‑2 in patients with acute cerebral infarction and reduced inflammation, and should therefore be incorporated in clinical practice.

View Figures

View References

1	Zhang M: Clinical research on traumatic cerebral infarction treated with mild-hypothermia and acupuncture. Zhongguo Zhen Jiu. 32:697–700. 2012.PubMed/NCBI(In Chinese).
2	Zhang X, Li Y, Liang Y, Sun P, Wu X, Song J, Sun X, Hong M, Gao P and Deng D: Distinguishing Intracerebral Hemorrhage from Acute Cerebral Infarction through Metabolomics. Rev Invest Clin. 69:319–328. 2017.PubMed/NCBI View Article : Google Scholar
3	Muramatsu K, Fujino Y, Kubo T, Otani M, Fushimi K and Matsuda S: Efficacy of antimicrobial catheters for prevention of catheter-associated urinary tract infection in acute cerebral infarction. J Epidemiol. 28:54–58. 2017.PubMed/NCBI View Article : Google Scholar
4	Juttler E, Kohrmann M and Schellinger PD: Therapy for early reperfusion after stroke. Nat Clin Pract Cardiovasc Med. 3:656–663. 2006.PubMed/NCBI View Article : Google Scholar
5	Varga V, Waje-Andreassen U, Naess H, Naess H, Lundstadsveen MT and Thomassen L: Thrombolytic therapy in cerebral infarction. Tidsskr Nor Laegeforen. 129:2214–2117. 2009.PubMed/NCBI View Article : Google Scholar : (In Norwegian).
6	Peng X, Yue W, Liu W, Dan B, Lin L and Tang Z: Protective roles of intra-arterial mild hypothermia and arterial thrombolysis in acute cerebral infarction. Springerplus. 5(1988)2016.PubMed/NCBI View Article : Google Scholar
7	Cechmanek BK, Tuor UI, Rushforth D and Barber PA: Very Mild hypothermia (35°C) postischemia reduces infarct volume and blood/brain barrier breakdown following tPA Treatment in the Mouse. Ther Hypothermia Temp Manag. 5:203–208. 2015.PubMed/NCBI View Article : Google Scholar
8	Moon Y, Lee JH, Cho HJ, Roh HG, Choi JW, Chun YI and Kim HY: Intravenous thrombolysis in a patient with acute ischemic stroke attributable to intracranial dissection. Neurologist. 18:136–138. 2012.PubMed/NCBI View Article : Google Scholar
9	Miyauchi T, Wei EP and Povlishock JT: Evidence for the therapeutic efficacy of either mild hypothermia or oxygen radical scavengers after repetitive mild traumatic brain injury. J Neurotrauma. 31:773–781. 2014.PubMed/NCBI View Article : Google Scholar
10	Guan Y, Zhao GD, Jiang L, et al: Meta-analysis of mild hypothermia in the treatment of acute ischemic stroke. J Practical Med. 29:1518–1521. 2013.
11	Chinese Medical Association Neurology Branch. Chinese Medical Association Neurology Branch Cerebrovascular Disease Group: Chinese guidelines for the diagnosis and treatment of acute ischemic stroke, 2014. Chin J Neurol. 48:246–257. 2015.
12	Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, et al: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 274:1017–1025. 1995.PubMed/NCBI
13	Kruyt ND and Roos YWBM: Hyperglycemia in Acute Stroke: Humana Press, 2010.
14	Wu Y and Zhang X: Cost-effectiveness comparison of four drug regimens in the treatment of acute cerebral infarction. Chin J Biochem Pharmaceutics. 31:57–58. 2010.(In Chinese).
15	Wang X, Shen B, Sun D and Cui X: Aspirin ameliorates cerebral infarction through regulation of TLR4/NF-κB-mediated endoplasmic reticulum stress in mouse model. Mol Med Rep. 17:479–487. 2018.PubMed/NCBI View Article : Google Scholar
16	Nakatani Y, Suto Y, Fukuma K, Yamawaki M, Sakata R, Takahashi S, Nakayasu H and Nakashima K: Intrathecal isoniazid for refractory tuberculous meningitis with cerebral infarction. Int Med. 56:953–957. 2017.PubMed/NCBI View Article : Google Scholar
17	Fang ZQ: Experimental Methodology of Dialectical Treatment of Rats/Mice, Science Press, 2009.
18	Jiang Y and Lian YJ: Effects of Danhong injection on hemodynamics and the inflammation-related NF-κB signaling pathway in patients with acute cerebral infarction. Genet Mol Res. 14:16929–16937. 2015.PubMed/NCBI View Article : Google Scholar
19	Yang J and Yang Z: Changes of serum TNF-α sICAM-1 in patients with cerebral infarction and its clinical significance. J Brain Nervous Dis. 10:39–41. 2002.(In Chinese).
20	Kochanek PM and Hallenbeck JM: Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. 23:1367–1379. 1992.PubMed/NCBI View Article : Google Scholar
21	del Zoppo GJ, Schmidschönbein GW, Mori E, Copeland BR and Chang CM: Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke. 22:1276–1283. 1991.PubMed/NCBI View Article : Google Scholar
22	Yang Y, Wu J and Sui Z: Tumor necrosis factor and cerebral ischemia. Zhejiang J Integrated Trad Chin Western Med. 19:60–61. 2009.(In Chinese).
23	Hu Xiao, Qi Hao, Li Shirong, et al: The efficacy and possible mechanism of intravenous thrombolysis combined with mild hypothermia in patients with acute cerebral infarction. Chin J Neuropsychiatric Dis. 42:15–21. 2016.(In Chinese).
24	Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, Lu SH, Yang YD, Fang Q, Shen YZ, et al: Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 368:2277–2285. 2013.PubMed/NCBI View Article : Google Scholar
25	Husain M: Avian influenza A (H7N9) virus infection in humans: epidemiology, evolution, and pathogenesis. Infect Genet Evol. 28:304–312. 2014.PubMed/NCBI View Article : Google Scholar
26	Deng H, Han HS, Cheng D, Sun GH and Yenari MA: Mild hypothermia inhibits inflammation after experimental stroke and brain inflammation. Stroke. 34:2495–2501. 2003.PubMed/NCBI View Article : Google Scholar
27	Chang YP, Liao PT, Shen EY and Liu IH: Protective effect against focal cerebral ischemia injury in acute phase of a novel invasive device for regional hypothermia. J Chin Med Assoc. 78:67–75. 2014.PubMed/NCBI View Article : Google Scholar
28	Liang J: Effects of body temperature control on serum S-100B protein, LDH expression and prognosis in patients with severe head injury. Chin Laboratory Diagnosis. 20(755)2016.(In Chinese).
29	Hu W, Dai Y, Chen S, et al: Clinical study of brain hypothermia on brain protection in patients with cerebral infarction. Chongqing Med J. 45:4817–4819. 2016.(In Chinese).
30	Andresen M, Gazmuri JT, Marín A, Regueira T and Rovegno M: Therapeutic hypothermia for acute brain injuries. Scand J Trauma Resusc Emerg Med. 23(42)2015.PubMed/NCBI View Article : Google Scholar
31	Guo XY, Li AQ, Zhan J, et al: Effects of local mild hypothermia on serum NSE in patients with severe cerebral infarction. Stroke and Neurological Diseases. 19:214–216. 2012.